Antibody Therapeutics Inc.
Power of cure over Fibrosis and Cancer
Mission
New therapy to bedside ASAP
Disease
- Pulmonary fibrosis
- NASH/cirrhosis
- Cardiac failure
- Chronic kidney disease
Science
- A particular cell-matrix whispering
- Find the the communication mediator
- Break the occasional blow up
- By blocking integrins with mAb
Pipeline
- ATI-235
- ATI-180
- ATI-611
- Pre-seeds against MCPs
Consulting
Experience the fusion of imagination and expertise with Études Architectural Solutions.
Project Management
Experience the fusion of imagination and expertise with Études Architectural Solutions.
Architectural Solutions
Experience the fusion of imagination and expertise with Études Architectural Solutions.
Technology
Current focus on the fibroblast integrin subfamily
Our perpetual conceptual target is the cell-matrix communication
Fibroblasts
- Repair tissue micro-injury by producing matrix-proteins
- Showcase your projects.
- Experience the world of architecture.
Matrix proteins
- A world of thought-provoking articles.
- Case studies that celebrate architecture.
- Exclusive access to design insights.
Science has a power of involvement
Yasuyuki Yokosaki
CEO, Antibody Therapeutics Inc.